Der var betænkelighed ved, at hovedundersøgelsen af Cerepro omfattede så få patienter, at fordelen ved lægemidlet ikke kunne påvises.
It was concerned over the low number of patients included in the main study of Cerepro, which prevented a benefit of the medicine being demonstrated.